Used primarily as an intermediate in pharmaceutical synthesis, this compound plays a key role in the preparation of bioactive molecules through Suzuki-Miyaura cross-coupling reactions. Its boronate ester functionality allows for efficient carbon-carbon bond formation, making it valuable in the development of drug candidates targeting central nervous system disorders and oncology. The piperazine moiety enhances solubility and binding affinity to biological targets, improving pharmacokinetic properties in final active pharmaceutical ingredients. It is also employed in the synthesis of kinase inhibitors and receptor modulators due to its structural compatibility with heterocyclic drug architectures.